These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 21421581

  • 1. Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09).
    Castanheira M, Mendes RE, Woosley LN, Jones RN.
    J Antimicrob Chemother; 2011 Jun; 66(6):1409-11. PubMed ID: 21421581
    [No Abstract] [Full Text] [Related]

  • 2. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
    Nijssen S, Florijn A, Bonten MJ, Schmitz FJ, Verhoef J, Fluit AC.
    Int J Antimicrob Agents; 2004 Dec; 24(6):585-91. PubMed ID: 15555882
    [Abstract] [Full Text] [Related]

  • 3. First national surveillance of susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. to antimicrobials in Israel.
    Colodner R, Samra Z, Keller N, Sprecher H, Block C, Peled N, Lazarovitch T, Bardenstein R, Schwartz-Harari O, Carmeli Y, Israel ESBL Group.
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):201-5. PubMed ID: 17258084
    [Abstract] [Full Text] [Related]

  • 4. High incidence of extended-spectrum beta-lactamases among outpatient clinical isolates of Escherichia coli: a phenotypic assessment of NCCLS guidelines and a commercial method.
    Sorlózano A, Gutiérrez J, Palanca M, Soto MJ, Piédrola G.
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):131-4. PubMed ID: 15474323
    [Abstract] [Full Text] [Related]

  • 5. Long-term study of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
    Polwichai P, Trakulsomboon S, Dejsirilert S, Thongmali O, Sawanpanyalert P, Aswapokee N, Buppanharun W.
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S53-8. PubMed ID: 21294502
    [Abstract] [Full Text] [Related]

  • 6. The prevalence of ESBL-producing E. coli and Klebsiella strains in the Copenhagen area of Denmark.
    Kjerulf A, Hansen DS, Sandvang D, Hansen F, Frimodt-Møller N.
    APMIS; 2008 Feb; 116(2):118-24. PubMed ID: 18321362
    [Abstract] [Full Text] [Related]

  • 7. Predominance of CTX-M-15 extended spectrum beta-lactamases in diverse Escherichia coli and Klebsiella pneumoniae from hospital and community patients in Kuwait.
    Ensor VM, Jamal W, Rotimi VO, Evans JT, Hawkey PM.
    Int J Antimicrob Agents; 2009 May; 33(5):487-9. PubMed ID: 19097760
    [No Abstract] [Full Text] [Related]

  • 8. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S, Muniandy S, Navaratnam P.
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [Abstract] [Full Text] [Related]

  • 9. Klebsiellapneumoniae isolates possessing KPC beta-lactamase in Israel, Puerto Rico, Colombia and Greece.
    Hawser SP, Bouchillon SK, Hoban DJ, Hackel M, Johnson JL, Badal RE.
    Int J Antimicrob Agents; 2009 Oct; 34(4):384-5. PubMed ID: 19560904
    [No Abstract] [Full Text] [Related]

  • 10. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004).
    Goossens H, Grabein B.
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):257-64. PubMed ID: 16360549
    [Abstract] [Full Text] [Related]

  • 11. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P, Metan G, Hasçelik G, Akova M.
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [Abstract] [Full Text] [Related]

  • 12. High frequency of beta-lactam susceptibility in CTX-M-type extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis according to the new CLSI recommendations.
    de Oliveira KR, de Freitas AL, Willers DM, Barth AL, Zavascki AP.
    J Antimicrob Chemother; 2010 Nov; 65(11):2481-3. PubMed ID: 20846935
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of in vitro activity of ertapenem with other carbapenems against extended-spectrum beta-lactamase-producing Escherichia coli and Kleibsella species isolated in a tertiary children's hospital.
    Devrim I, Gulfidan G, Gunay I, Agın H, Güven B, Yılmazer MM, Dizdarer C.
    Expert Opin Pharmacother; 2011 Apr; 12(6):845-9. PubMed ID: 21323503
    [Abstract] [Full Text] [Related]

  • 14. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea.
    Kim J, Lim YM, Rheem I, Lee Y, Lee JC, Seol SY, Lee YC, Cho DT.
    FEMS Microbiol Lett; 2005 Apr 01; 245(1):93-8. PubMed ID: 15796985
    [Abstract] [Full Text] [Related]

  • 15. Re: A VIM-1-metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
    Shah PM.
    Int J Antimicrob Agents; 2009 Oct 01; 34(4):381. PubMed ID: 19502012
    [No Abstract] [Full Text] [Related]

  • 16. Emergence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae during the years 2000 and 2004 in Helsinki, Finland.
    Forssten SD, Kolho E, Lauhio A, Lehtola L, Mero S, Oksaharju A, Jalava J, Tarkka E, Vaara M, Vuopio-Varkila J.
    Clin Microbiol Infect; 2010 Aug 01; 16(8):1158-61. PubMed ID: 20670290
    [Abstract] [Full Text] [Related]

  • 17. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
    Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A, Norwegian ESBL Study Group.
    J Clin Microbiol; 2007 Jan 01; 45(1):199-205. PubMed ID: 17079502
    [Abstract] [Full Text] [Related]

  • 18. In vitro susceptibilities of clinical isolates of Escherichia coli and Klebsiella species to CSE1034 and other β-lactams.
    Chaudhary M, Kumar S, Payasi A.
    J Antibiot (Tokyo); 2013 Aug 01; 66(8):495-7. PubMed ID: 23612723
    [No Abstract] [Full Text] [Related]

  • 19. Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli?
    You JH, Kei HW, Lau WC, Wong KY, Marasinghe T, Lee N, Ip M.
    J Hosp Infect; 2008 Feb 01; 68(2):181-3. PubMed ID: 18194826
    [No Abstract] [Full Text] [Related]

  • 20. Epidemiology and outcome of bacteremia caused by extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in a tertiary care teaching hospital in south India.
    Abhilash KP, Veeraraghavan B, Abraham OC.
    J Assoc Physicians India; 2010 Dec 01; 58 Suppl():13-7. PubMed ID: 21563608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.